UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060622
Receipt number R000069340
Scientific Title Relationship between laser therapy and erythema
Date of disclosure of the study information 2026/02/10
Last modified on 2026/02/09 12:31:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between laser therapy and erythema

Acronym

Relationship between laser therapy and erythema

Scientific Title

Relationship between laser therapy and erythema

Scientific Title:Acronym

Relationship between laser therapy and erythema

Region

Japan


Condition

Condition

Dermal melanocytosis

Classification by specialty

Dermatology Anesthesiology Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to investigate the causes of erythema occurring during laser treatment.

Basic objectives2

Others

Basic objectives -Others

Additional items if necessary

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum tryptase level

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Blood sampling

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who consent to blood sampling

Key exclusion criteria

Patients who do not consent to blood sampling

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Tohru
Middle name
Last name Shiratori

Organization

Ina Central Hospital

Division name

Division of Anesthesia

Zip code

3968555

Address

1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan

TEL

0265723121

Email

ts_62475@inahp.jp


Public contact

Name of contact person

1st name Tohru
Middle name
Last name Shiratori

Organization

Ina Central Hospital

Division name

Division of Anesthesia

Zip code

3968555

Address

Division of Anesthesia

TEL

0265723121

Homepage URL


Email

ts_62475@inahp.jp


Sponsor or person

Institute

Ina Central Hospital

Institute

Department

Personal name



Funding Source

Organization

Ina Central Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ina central Hospital

Address

1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan

Tel

0265723121

Email

info@inahp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 12 Day

Date of IRB


Anticipated trial start date

2026 Year 02 Month 10 Day

Last follow-up date

2036 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 09 Day

Last modified on

2026 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069340